|
⚲
|
| Keyboard |
| Armistice Capital LLC
✚
|
|
|---|---|
| CRD # | 168978 |
| SEC # | 801-100464 |
| CIK # | 0001601086 |
| AUM | 4,724.7 M (2026-03-31) |
| Employees | 30 (63% Investors, 0% Brokers) |
| Phone | 212-231-4930 |
| Address | 510 Madison Ave New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($B) |
|---|
| In the News | |
|---|---|
| Mon, 22 Jun 2026 | Citigroup's Upgrade Caps a Run of Bullish Calls on PTC Therapeutics, a Major Armistice Capital Holding — Daily Cal |
| Tue, 19 May 2026 | InMed cuts preferred option exercise price from $16.60 to $0.80 in deal with Armistice Capital — Pluang |
| Tue, 28 Apr 2026 | Jury Clears Armistice Capital, Execs Of Securities Fraud — law360.com |
| Wed, 15 Apr 2026 | Defense says Armistice Capital trades, not fraud, drove Vaxart stock sales — Daily Journal |
| Tue, 14 Apr 2026 | Armistice Capital Used COVID To Juice Vaxart Stock, Jury Told — law360.com |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Agios Pharmaceuticals Inc | 0.2 | ||
| Cytokinetics Inc | 0.2 | ||
| PTC Therapeutics Inc | 0.2 | ||
| Desert Gateway Inc | 0.1 | ||
| Synta Pharmaceuticals Corp | 0.1 | ||
| Health Sciences Acquisitions Corp | 0.1 | ||
| Supernus Pharmaceuticals Inc | 0.1 | ||
| Neurocrine Biosciences Inc | 0.1 | ||
| Freshpet Inc | 0.1 | ||
| Incyte Corp | 0.1 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Armistice Capital Master Fund Ltd | [2013-10-03] | 704.6 M | 4,724.7 M |
| Filed 2025-09-05 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 4.7 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 4.7 |
| By Discretionary | ||
| Discretionary | 3 | 4.7 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 4.7 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 4.7 | |
| Total | 3 | 4.7 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Steven Boyd | Executive Officer | 17 | 2 | |
| Armistice Capital LLC | Executive Officer | 2 | 2 | |
| Armistice Capital GP LLC | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001601086] | |
| 3 | [0001601086] | |
| 4 | [0001601086] | |
| SC 13D | [0001601086] | |
| SC 13G | [0001601086] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 549300KF4D500QMUP976 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2023-06-27 | Sell | 937,404 | $0.52 | 487,450 |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2023-06-26 | Sell | 2,746,138 | $0.61 | 1,675,144 |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2023-02-07 | Buy | 450,000 | ||
|
Avalo Therapeutics Inc AVTX
Warrant · derivative
|
2023-02-07 | Buy | 450,000 | ||
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2023-02-03 | Small acquisition | 334 | $3.95 | 1,319 |
|
Tenax Therapeutics Inc TENX
Series B Common Stock Purchase Warrants · derivative
|
2022-05-18 | Disposed to issuer | 3,175,924 | ||
|
Tenax Therapeutics Inc TENX
Common Stock Purchase Warrants · derivative
|
2022-05-18 | Grant | 2,072,538 | ||
|
Tenax Therapeutics Inc TENX
Warrant (right to buy) · derivative
|
2022-05-18 | Grant | 4,773,269 | ||
|
Tenax Therapeutics Inc TENX
Common Stock Purchase Warrants · derivative
|
2022-05-18 | Grant | 2,360,313 | ||
|
Tenax Therapeutics Inc TENX
Series C Common Stock Purchase Warrants · derivative
|
2022-05-18 | Disposed to issuer | 4,607,692 | ||
|
Tenax Therapeutics Inc TENX
Series B Common Stock Purchase Warrants · derivative
|
2022-05-18 | Grant | 3,175,924 | ||
|
Tenax Therapeutics Inc TENX
Common Stock Purchase Warrants · derivative
|
2022-05-18 | Disposed to issuer | 2,072,538 | ||
|
Tenax Therapeutics Inc TENX
Series C Common Stock Purchase Warrants · derivative
|
2022-05-18 | Grant | 10,596,027 | ||
|
Tenax Therapeutics Inc TENX
Series C Common Stock Purchase Warrants · derivative
|
2022-05-18 | Grant | 4,607,692 | ||
|
Tenax Therapeutics Inc TENX
Common Stock Purchase Warrants · derivative
|
2022-05-18 | Disposed to issuer | 2,360,313 | ||
|
Tenax Therapeutics Inc TENX
Warrant (right to buy) · derivative
|
2022-05-18 | Disposed to issuer | 4,773,269 | ||
|
Tenax Therapeutics Inc TENX
Pre-Funded Common Stock Purchase Warrants · derivative
|
2022-05-18 | Grant | 10,596,027 | ||
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2022-03-14 | Buy | 100,000 | $0.65 | 65,000 |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2022-03-11 | Buy | 100,000 | $0.69 | 69,000 |
|
Avalo Therapeutics Inc AVTX
Common Stock
|
2022-03-10 | Buy | 26,000 | $0.70 | 18,200 |
| showing 20 of 200 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Encompass Capital Advisors LLC
✚
|
NY | 4,835.4 M |
|
DME Capital Management LP
✚
|
NY | 4,798.9 M |
|
Covalis Capital LLP
✚
|
4,788.9 M | |
|
Covalis Gibraltar Limited
✚
|
4,760.4 M | |
|
Mesarete Capital LLP
✚
|
4,746.1 M | |
|
Acasta Partners US LLC
✚
|
FL | 4,722.4 M |
|
Yaupon Capital Management LP
✚
|
NY | 4,684.2 M |
|
Route One Investment Company LP
✚
|
CA | 4,681.7 M |
|
Clean Energy Transition LLP
✚
|
4,630.7 M | |
|
Summit Partners Public Asset Management LLC
✚
|
MA | 4,617.4 M |